Triller Group Inc. (ILLR): Nasdaq/NYSE listing notice — Triller Group receives Nasdaq minimum bid price deficiency notice; 180 days to cure

Triller Group Inc.

Received Nasdaq letter on June 30, 2025 for non-compliance with $1 minimum bid price requirement.
Has 180 calendar days until December 29, 2025 to regain compliance.
Must have closing bid price of at least $1 per share for 10 consecutive business days.
If not cured, may seek additional 180-day period if eligible and consider reverse stock split.
No immediate delisting; company monitoring options and cannot assure compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Triller Group Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

e Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until December 29, 2025, in which to regain compliance. In order to regain compliance with the Minimum Bid Price Requirement, the cl

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Triller Group Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-061740

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.